Correlation Between General Insurance and Krebs Biochemicals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both General Insurance and Krebs Biochemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining General Insurance and Krebs Biochemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Insurance and Krebs Biochemicals and, you can compare the effects of market volatilities on General Insurance and Krebs Biochemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in General Insurance with a short position of Krebs Biochemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of General Insurance and Krebs Biochemicals.

Diversification Opportunities for General Insurance and Krebs Biochemicals

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between General and Krebs is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding General Insurance and Krebs Biochemicals and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krebs Biochemicals and and General Insurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Insurance are associated (or correlated) with Krebs Biochemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krebs Biochemicals and has no effect on the direction of General Insurance i.e., General Insurance and Krebs Biochemicals go up and down completely randomly.

Pair Corralation between General Insurance and Krebs Biochemicals

Assuming the 90 days trading horizon General Insurance is expected to generate 3.99 times less return on investment than Krebs Biochemicals. But when comparing it to its historical volatility, General Insurance is 3.16 times less risky than Krebs Biochemicals. It trades about 0.16 of its potential returns per unit of risk. Krebs Biochemicals and is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  8,053  in Krebs Biochemicals and on August 31, 2024 and sell it today you would earn a total of  2,361  from holding Krebs Biochemicals and or generate 29.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

General Insurance  vs.  Krebs Biochemicals and

 Performance 
       Timeline  
General Insurance 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days General Insurance has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, General Insurance is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Krebs Biochemicals and 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

General Insurance and Krebs Biochemicals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with General Insurance and Krebs Biochemicals

The main advantage of trading using opposite General Insurance and Krebs Biochemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if General Insurance position performs unexpectedly, Krebs Biochemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krebs Biochemicals will offset losses from the drop in Krebs Biochemicals' long position.
The idea behind General Insurance and Krebs Biochemicals and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum